Chandan Healthcare Limited

NSE-CHANDAN
National Stock Exchange of India
Healthcare Medical Laboratories
Global Rank
#30375
Country Rank
#1960
Market Cap
51.32 M
Price
3.5
Change (%)
5.00%
Volume
156,000

Chandan Healthcare Limited's latest marketcap:

51.32 M

As of 10/21/2025, Chandan Healthcare Limited's market capitalization has reached $51.32 M. According to our data, Chandan Healthcare Limited is the 30375th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 51.32 M
Revenue (ttm) 26.29 M
Net Income (ttm) 2.52 M
Shares Out 24.45 M
EPS (ttm) 0.12
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 11/26/2025
Market Cap Chart
Data Updated: 10/21/2025

Chandan Healthcare Limited's yearly market capitalization.

Date Market Cap(₹) Market Cap(USD) Change (%) Global Rank
10/21/2025 ₹4.38 B $51.32 M 30375

Company Profile

Chandan Healthcare Limited operates laboratories in India.

It offers pathology services, such as biochemistry, hematology, histopathology, microbiology, and immunology tests, as well as radiology services, including x-rays, ultrasonography, computed tomography (CT) scan, magnetic resonance imaging services.

The company was incorporated in 2003 and is based in Lucknow, India.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.